Since EWS::FLI1 depends on these acetyltransferases to sustain enhancer activity and regulate tumor-promoting genes, inhibiting their enzymatic functions leads to EWS::FLI1 destabilization and enhanced therapeutic sensitivity. The gene discussed is FLI1; the disease is neoplasm.